Kaken Pharmaceutical Co Ltd
TSE:4521
Kaken Pharmaceutical Co Ltd
Cash from Financing Activities
Kaken Pharmaceutical Co Ltd
Cash from Financing Activities Peer Comparison
Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors
Company | Cash from Financing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
K
|
Kaken Pharmaceutical Co Ltd
TSE:4521
|
Cash from Financing Activities
-¥5.6B
|
CAGR 3-Years
11%
|
CAGR 5-Years
10%
|
CAGR 10-Years
5%
|
Takeda Pharmaceutical Co Ltd
TSE:4502
|
Cash from Financing Activities
-¥302.8B
|
CAGR 3-Years
29%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Daiichi Sankyo Co Ltd
TSE:4568
|
Cash from Financing Activities
-¥123.5B
|
CAGR 3-Years
4%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
N/A
|
|
Otsuka Holdings Co Ltd
TSE:4578
|
Cash from Financing Activities
-¥60.3B
|
CAGR 3-Years
17%
|
CAGR 5-Years
8%
|
CAGR 10-Years
2%
|
|
Chugai Pharmaceutical Co Ltd
TSE:4519
|
Cash from Financing Activities
-¥139.3B
|
CAGR 3-Years
-12%
|
CAGR 5-Years
-32%
|
CAGR 10-Years
-20%
|
|
Astellas Pharma Inc
TSE:4503
|
Cash from Financing Activities
¥478.6B
|
CAGR 3-Years
53%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Kaken Pharmaceutical Co Ltd's Cash from Financing Activities?
Cash from Financing Activities
-5.6B
JPY
Based on the financial report for Dec 31, 2023, Kaken Pharmaceutical Co Ltd's Cash from Financing Activities amounts to -5.6B JPY.
What is Kaken Pharmaceutical Co Ltd's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 10Y
5%
Over the last year, the Cash from Financing Activities growth was 20%. The average annual Cash from Financing Activities growth rates for Kaken Pharmaceutical Co Ltd have been 11% over the past three years , 10% over the past five years , and 5% over the past ten years .